Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02627742
Other study ID # CR-RR2015-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date August 2017

Study information

Verified date January 2024
Source Baxter Healthcare Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine if a therapy regimen including treatment with The MetaNeb® System had a positive impact on the rate of pulmonary complications related to atelectasis and/or secretion retention that occur in high risk post-operative patients. This is a non-randomized facility (or hospital) level pre-post intervention study.


Description:

Post-operative pulmonary complications (PPC) are associated with significant excess morbidity, mortality and healthcare expenditure. Although PPCs are an incompletely understood multifactorial syndrome, atelectasis is recognized as a critical component. A variety of strategies have been shown to reduce the risk for development of post-operative atelectasis including lung expansion (LE) therapies. Well-designed studies are needed to distinguish which LE approach has the greatest potential to optimize patient care, clinical outcomes and cost savings. Intrapulmonary percussive ventilation (IPV) devices have been in use for more than 25 years and are used widely in the acute care, post-surgical, and homecare setting. Such devices provide both LE and airway clearance therapy (ACT) for patients with obstructive and/or restrictive lung diseases and conditions. The MetaNeb® System is an LE expansion modality that incorporates all the physiological effects of IPV while providing additional therapeutic advantages intended primarily to more effectively treat or prevent pulmonary atelectasis. The study was be conducted in two stages. In Stage I of the study, a retrospective review of medical records for post-surgical patients, who received STANDARD THERAPY as defined by current hospital and respiratory care department policies and procedures was performed. In Stage II, a CHANGE IN PRACTICE was made and patients received standard care with the addition of therapy with The MetaNeb® System. Demographic, clinical & outcome data was collected for eligible patients during the two stages of the study. Study staff collected data from the medical records, following a protocol determined schedule.


Recruitment information / eligibility

Status Completed
Enrollment 419
Est. completion date August 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Age = 18 years Post-thoracic, -upper abdominal or -aortic surgery Open surgical procedure Incision at or above the umbilicus High risk defined by: Documented ASA class = 3 OR Documented ASA class 2 AND One or more of the following: Current smoker or smoking history within past 6 months History of COPD Documented obesity and/or BMI = 30 kg/m2 Age = 75 Exclusion Criteria: Contraindication to Continuous High Frequency Oscillation (CHFO) therapy Minimally invasive, or ". . . scopic" procedure. Spinal surgery involving a posterior approach. Surgery for organ transplant. Chronic invasive positive pressure ventilation (PPV)

Study Design


Intervention

Device:
MetaNeb® System
The treatment protocol used for Respiratory Care during the CHANGE IN PRACTICE period of the Study will be that prescribed by the patient's health care team in the routine standard care of each patient. With the exception of standard airway clearance and lung expansion procedures, other components of the patients respiratory care regimen will remain the same as during the standard therapy period, however the CHANGE IN PRACTICE will incorporate the use/treatment with The MetaNeb® System as an alternative to usual airway clearance and lung expansion procedures. Use of The MetaNeb® System will follow the labeling of the device.

Locations

Country Name City State
United States Lahey Hospital and Medical Center Burlington Massachusetts
United States Carolinas Medical Center Charlotte North Carolina
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Hill-Rom

Country where clinical trial is conducted

United States, 

References & Publications (1)

Huynh TT. et al.,

Outcome

Type Measure Description Time frame Safety issue
Primary Significant Postoperative Pulmonary Complication Incidence. One or more of the following that occurs within seven (7) days of the post-surgical admission will be considered a Significant Postoperative Pulmonary Complication (PPC)
Patient requires prolonged mechanical ventilation (> 24 hours from post-surgical admission)
Patient requires prolonged respiratory support for > 24 hours from post-surgical admission
Diagnosis of pneumonia within seven (7) days
Readmission to ICU for pulmonary complications within seven (7) days of post-surgical hospital admission
Within seven (7) days of the post-surgical admission
Secondary Requirement for Invasive Mechanical Ventilation for > 48 Hours Within Seven (7) Days of the Post-surgical Hospital Admission Defined as patient requirement for invasive mechanical ventilation (MV) for > 48 hours (after hour 48) post-operatively. This includes patients that require re-intubation after hour 48, regardless of length of time on MV in the first 48 hours postoperatively. 7 days (From the time of post-surgical admission to the hospital through day 7 following the initial post-surgical admission)
Secondary Requirement for Respiratory Support > 48 Hours Within Seven (7) Days of the Post-surgical Hospital Admission Respiratory support greater than the patient's baseline level for a period longer than 48 hours
Requirement for non-invasive ventilation (NIV) above patient's baseline requirement after hour 48 from post-surgical admission or continuous positive airway pressure (CPAP) above patient's baseline requirement after hour 48.
Requirement for O2 therapy > 40 % FiO2 or > 5 LPM pm via Nasal Cannula (and above patient's baseline) after hour 48 postoperatively.
7 days (From the time of post-surgical admission to the hospital through day 7 following the initial post-surgical admission)
Secondary Length of ICU Stay During Initial Hospital Stay ICU length of stay, during initial hospital stay, was determined by calculating the number of days/hours spent in ICU. The following was documented:
Time of admission to the ICU to actual time of initial discharge from the ICU during initial hospital stay
Total ICU days/hours (includes readmissions) during initial hospital stay
Total days/hours until time of discharge from the hospital, up to 8 weeks
Secondary Length of Hospital Stay During Initial Hospital Stay Hospital length of stay was determined by calculating the number of days/hours spent in hospital. The following was documented:
• Time of admission to time of discharge from the hospital (total days/hours)
Time of admission until time of discharge from the hospital, up to 8 weeks
Secondary Readmission to ICU and Transfers to Elevated Level of Care for Pulmonary Complications During Initial Hospital Stay Readmissions to ICU and transfers to an elevated level of care, during the initial hospital stay, was documented for each event. The following was documented:
Number of readmission to ICU or elevated level of care events
Number of patients requiring readmission to the ICU or to an elevated level of care
during hospital stay, up to 8 weeks
Secondary Readmission to Hospital Hospital records were reviewed at each site, 30 days after the last patient has been discharged from the hospital. Readmissions, for any cause, within 30 days of discharge for any study patient were documented. 30 days following discharge from the hospital
Secondary Time on Mechanical Ventilation Time to initial extubation from time of initial intubation, if initial intubation was placed after surgery; or from time of post-surgical admission, if intubation was in place prior to start of surgery
Total time on invasive mechanical ventilation - was determined for each patient by calculating the total number of days/hours intubated and mechanically ventilated from the time of post-surgical admission until the time of initial hospital discharge.
Total time on non-invasive ventilation - was determined for each patient by calculating the total number of days/hours ordered for non-invasive ventilation from the time of post-surgical admission to the hospital unit until the time of initial hospital discharge.
total hours/days from the time of the post-surgical admission to the hospital unit until time of discharge from the hospital, up to 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06021249 - Comparing Innovative and Traditional Ventilation Strategies on Atelectasis and Prognosis in Elderly Patients N/A
Terminated NCT03581474 - Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting N/A
Completed NCT02871258 - MetaNeb® Chest X-ray Study N/A
Completed NCT02523755 - Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia Phase 4
Completed NCT02232841 - Electrical Impedance Imaging of Patients on Mechanical Ventilation N/A
Completed NCT02216006 - High Fresh Gas Flow After Intubation N/A
Completed NCT01416519 - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation N/A
Completed NCT03153592 - Effects of Mechanical Ventilation Guided by Transpulmonary Pressure on Gas Exchange During Robotic Surgery: a Pilot Study N/A
Completed NCT03694665 - Monitoring Lung Recruitment Maneuver in Anesthetized Morbidly Obese N/A
Completed NCT04506203 - The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool N/A
Not yet recruiting NCT06296173 - Open Lung Protective Extubation Following General Anesthesia N/A
Completed NCT04006665 - Role of Lung Ultrasonography in Diagnosing Atelectasis in Robotic Pelvic Surgeries
Completed NCT03614845 - Evaluation of Effect of Different Ventilator Mods on Atelectasis in Patients Undergoing Laparoscopic Surgery N/A
Active, not recruiting NCT06075836 - AI Assisted Detection of Chest X-Rays
Completed NCT01993394 - Effect of Hyperoxia and Hypergravity on Lung Ventilation and Perfusion N/A
Completed NCT00671723 - Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis in Non-Cystic Fibrosis Patients N/A
Completed NCT03378752 - Atelectasis Formation Using HFJV During Stereotactic Solid Organ Ablations
Completed NCT05963945 - Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice
Completed NCT03592589 - Prevention of Atelectasis, Via High Flow Nasal Cannula to Obtain a PEP, During General Anesthesia in Children N/A
Completed NCT04458623 - Air Test In Diagnosis Of Postoperative Lung Atelectasis N/A